3.Can Magnetic Resonance Elastography Fill a Niche in the Market for Noninvasive Assessment of Liver Fibrosis?.
Gut and Liver 2017;11(3):321-322
No abstract available.
Elasticity Imaging Techniques*
;
Liver Cirrhosis*
;
Liver*
4.Liver stiffness measurement using FibroScan(R).
Korean Journal of Medicine 2008;74(5):463-471
Progressive liver fibrosis is a similar feature of all chronic liver diseases and eventually develops liver cirrhosis. The prognosis and treatment plans of chronic liver diseases depend strongly on the degree of liver fibrosis. These facts raise clinical interests in quantifying liver fibrosis. Although liver biopsy has been the gold standard for assessment of liver fibrosis, it has some technical limitations and risks. Accordingly, an increasing need for alternative non-invasive method to quantify liver fibrosis has been a major challenge that has stimulated search for new non-invasive methods. Such methods for diagnosing liver fibrosis have progressed significantly over the last few years notably with the appearance of several serological markers which have been reported to predict the presence of significant fibrosis or cirrhosis in patients with chronic liver disease with considerable accuracy. However, complicated calculation, cost problems, and influences of extrahepatic conditions make it less accessible to clinicians. Recently, liver stiffness measurement using FibroScan(R) is emerging as a new diagnostic method for liver fibrosis. It is totally non-invasive and reproducible and gives an immediate result without intra- and inter-observer variability. Its clinical use in comparison with liver biopsy and several available serologic markers is now intensively being investigated. Here, we review the currently available data on FibroScan(R).
Biopsy
;
Fibrosis
;
Humans
;
Liver
;
Liver Cirrhosis
;
Liver Diseases
;
Observer Variation
;
Prognosis
5.A case of isolated ACTH deficiency.
Seung Won CHOI ; Ki Up LEE ; Dong Wan SEO ; Ghi Su KIM ; Munho LEE
Journal of Korean Society of Endocrinology 1992;7(4):397-401
No abstract available.
Adrenocorticotropic Hormone*
6.Pharmacologic Treatment Using Non-Hypoglycemic Agents for Nonalcoholic Fatty Liver Disease.
Journal of Korean Diabetes 2018;19(2):97-100
Nonalcoholic fatty liver disease (NAFLD) is a common condition that may progress to end-stage liver disease. Recently, NAFLD has been recognized as a hepatic manifestation of metabolic syndrome and an independent risk factor for cardiovascular disease. Therefore, appropriate management of this common disorder is an important public health issue. The management of NAFLD is based on gradual weight loss through lifestyle modification. Reducing total calorie intake and carbohydrates in the diet is beneficial for NAFLD patients. Regular exercise reduces hepatic fat content independent of weight loss. However, such lifestyle changes are difficult to maintain long term for most patients. Despite the growing need for pharmacologic therapy, there is currently no effective agent for the treatment of NAFLD. Several large clinical trials have shown promising but inconsistent effects of pioglitazone and vitamin E for improving NAFLD. However, larger clinical trials are required before definitive conclusions can be drawn.
Carbohydrates
;
Cardiovascular Diseases
;
Diet
;
Humans
;
Life Style
;
Liver Diseases
;
Non-alcoholic Fatty Liver Disease*
;
Public Health
;
Risk Factors
;
Vitamin E
;
Vitamins
;
Weight Loss
7.Can Non-invasive Fibrosis Assessment Predict Sustained Virological Response to Telaprevir with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients?.
Mi Na KIM ; Jun Hyung KIM ; Seung Up KIM
The Korean Journal of Gastroenterology 2014;64(4):250-252
No abstract available.
Fibrosis*
;
Hepatitis C, Chronic*
;
Humans
;
Interferons*
;
Ribavirin*
8.A case of osteoporosis associated with pernicious anemia.
Sang Wook KIM ; Seung Won CHOI ; Jung Shin LEE ; Joong Yeol PARK ; Ki Up LEE ; Ghi Su KIM
Journal of Korean Society of Endocrinology 1993;8(3):351-355
No abstract available.
Anemia, Pernicious*
;
Osteoporosis*
9.Assessment of fibrotic burden among chronic hepatitis B virus-infected patients with normal transaminase level.
Mi Young JEON ; Beom Kyung KIM ; Seung Up KIM
Clinical and Molecular Hepatology 2018;24(4):367-369
No abstract available.
Classification
;
Elasticity Imaging Techniques
;
Hepatitis B virus
;
Hepatitis B, Chronic*
;
Hepatitis, Chronic*
;
Humans
;
Liver Cirrhosis
10.Advanced Stage Hepatocellular Carcinoma Successfully Treated with Liver-directed Concurrent Chemoradiotherapy and Sequential Transarterial Radio-embolization
Minho NOH ; Beom Kyung KIM ; Seung Up KIM
Journal of Liver Cancer 2021;21(1):97-103
Optimal treatment strategies for patients with advanced hepatocellular carcinoma (HCC) is yet to be determined. Herein, we present a case of advanced HCC with tumor invasion into the right anterior portal vein and right hepatic vein where complete response (CR) was achieved via a multidisciplinary approach. This patient had a 10.5 cm-sized HCC invading segment VI, without extrahepatic spread. Liver function was classified as Child-Pugh class A, and the performance status was good. Transarterial radio-embolization (TARE) was performed 6 weeks after the completion of liver-directed concurrent chemoradiotherapy, and CR was confirmed 3 months post-TARE. Adoptive cell therapies were performed as adjuvant therapy and CR was maintained for over 15 months, until the local recurrence of a 2 cm-sized HCC was found. Therefore, in selected cases with preserved liver function, combination therapies, including LRTs and systemic therapy, can be a useful therapeutic option for advanced HCC.